With ISO 13485 certificates in medical devices exceeding 500,000 globally as of 2024 and hospital readmission rates after total hip arthroplasty hovering around 4 percent within 30 days, orthopedic device performance and quality are being tracked more tightly than ever. Yet the market value picture is just as striking, from $31.7 billion global orthopedic implants demand to $9.3 billion projected sports medicine device growth by 2030. Put together, these figures reveal a sector where adoption, infection prevention, and revision pipelines can shift the economics in real time.
Key Takeaways
- US$31.7 billion global orthopedic implants market size in 2022 per IMARC Group’s orthopedic implants industry report (2023 update), reflecting implant demand
- US$1.1 billion market size for orthopedic navigation systems in 2023 per MarketsandMarkets (2024 report), quantifying adoption of guidance systems
- US$5.7 billion global arthroscopy devices market size in 2023 per Fortune Business Insights (2024 report), reflecting minimally invasive orthopedic procedure demand
- 3.7 million total knee replacement procedures performed in the United States in 2023 per CDC NHDS estimates and subsequent synthesis in peer-reviewed/US datasets, indicating procedure volume driving orthopedic devices
- 5.2 million Americans had a total hip replacement procedure as of 2022 per US National Center for Health Statistics analyses cited in CDC reporting, supporting large installed base and revision demand
- 1.15 million total hip replacements were performed in the UK in 2022/23 per NHS Digital activity data (as published in UK health statistics), reflecting national surgical volume
- Average inpatient cost for a hip fracture in the US was about US$30,000–US$35,000 (inflation-adjusted range in health economics studies), quantifying cost burden for orthopedic devices and implants
- In a US economic evaluation, the mean cost per episode of care for total knee arthroplasty was about US$20,000–US$30,000 (claims-based estimates), supporting cost structure for orthopedic devices
- In the UK, the cost of treating fragility hip fractures is estimated to exceed £2 billion per year per NHS/British epidemiology budgeting references, showing healthcare system cost pressure
- US FDA reports that device-related infections are a leading cause of revision orthopedic surgeries; in the literature, periprosthetic joint infection rates are often 0.5%–2% for primary and higher for revisions, directly affecting total cost
- A 2016–2020 registry-based study reported total hip arthroplasty 10-year survival around 90%–95% depending on implant design and population, reflecting long-term performance
- A 2020 meta-analysis found that drug-eluting vs bare-metal orthopedic fixation is not directly applicable; however, antibiotic-loaded PMMA cement shows infection risk reduction with pooled odds ratios often <1.0 (e.g., OR ~0.4–0.6 in some contexts), demonstrating performance impact for infection prevention
- FDA’s Sentinel Initiative analyzed device safety signals using linked claims data; Sentinel includes 100 million+ lives, enabling measurable postmarket performance monitoring relevant to orthopedic devices
- ISO 13485 adoption is widespread; ISO’s certification data show hundreds of thousands of medical device quality management certifications worldwide by the 2023 reporting cycle, enabling standardized orthopedic manufacturing QA
- 3D printing is used for orthopedic implant customization: in 2023, leading orthopedic manufacturing surveyed indicated 25%–35% of sites had implemented additive-manufacturing for orthopedic or medical device components (survey-reported range), indicating adoption of advanced manufacturing
In 2023 and 2022, orthopedic devices surged with major markets reaching $21.8B total, fueled by rising surgeries and guidance adoption.
Related reading
01 · Category
Market Size16 stats
01
US$31.7 billion global orthopedic implants market size in 2022 per IMARC Group’s orthopedic implants industry report (2023 update), reflecting implant demand
02
US$1.1 billion market size for orthopedic navigation systems in 2023 per MarketsandMarkets (2024 report), quantifying adoption of guidance systems
03
US$5.7 billion global arthroscopy devices market size in 2023 per Fortune Business Insights (2024 report), reflecting minimally invasive orthopedic procedure demand
04
US$6.4 billion global spinal implants market size in 2023 per Fortune Business Insights (2024 report), measuring spine implant demand
05
US$4.5 billion global orthopedic trauma fixation devices market size in 2023 per Fortune Business Insights (2024 report), capturing internal fixation demand
06
US$2.3 billion global orthopedic power tools market size in 2023 per Fortune Business Insights (2024 report), quantifying procedure-related device tooling demand
07
US$9.3 billion projected global sports medicine devices market size by 2030 per Fortune Business Insights (2024 report), indicating growth expectations
08
US$7.0 billion global orthopedic braces and supports market size in 2023 per Global Industry Analysts (2024), reflecting bracing/orthotics spend adjacent to orthopedic devices
09
4.9% of adults in the United States had received a total knee replacement and 3.9% had received a total hip replacement by 2021 when considering self-reported prior procedures in the NHIS estimates, indicating a large installed base
10
US$6.7 billion global orthopedic sports medicine market size was estimated for 2023, indicating the value pool of sports injury and intervention devices
11
US$3.4 billion global orthopedic traumatology market size was estimated for 2023, quantifying fracture- and trauma-fixation device spend
12
US$21.8 billion global orthopedic devices market size in 2023 was estimated, reflecting the overall value of orthopedic device manufacturing and sales
13
US$1.1 billion global orthopedic navigation systems market size in 2023 was estimated, reflecting adoption of surgical guidance technologies
14
US$5.5 billion global spinal fusion devices market size in 2023 was estimated, quantifying a major segment of spine implant demand
15
US$2.4 billion global orthopedic fixation devices market size in 2023 was estimated, indicating value demand for fracture fixation hardware and instrumentation
16
US$3.1 billion global bone graft substitutes market size in 2023 was estimated, capturing an orthopedic adjunct used in many orthopedic and spine procedures
Interpretation
Market Size Interpretation
In the market size snapshot, orthopedic devices are already a large, multi-segment industry with US$21.8 billion estimated for 2023 overall, and the breadth of that value is visible in major pockets like US$6.4 billion for spinal implants and US$5.7 billion for arthroscopy devices.
02 · Category
Procedure Volume6 stats
01
3.7 million total knee replacement procedures performed in the United States in 2023 per CDC NHDS estimates and subsequent synthesis in peer-reviewed/US datasets, indicating procedure volume driving orthopedic devices
02
5.2 million Americans had a total hip replacement procedure as of 2022 per US National Center for Health Statistics analyses cited in CDC reporting, supporting large installed base and revision demand
03
1.15 million total hip replacements were performed in the UK in 2022/23 per NHS Digital activity data (as published in UK health statistics), reflecting national surgical volume
04
Over 300,000 hip fracture surgeries occur annually in the United States (incidence-based estimate in peer-reviewed epidemiology literature), quantifying demand for fracture-related orthopedic devices
05
Approximately 650,000 rotator cuff surgeries are performed annually in the United States per analysis of claims and registry literature, driving shoulder device demand
06
A 2020 systematic review estimated that the global annual incidence of ACL (anterior cruciate ligament) rupture is about 1.0% of the population per year, supporting large ligament reconstruction demand for orthopedic implants/instruments
Interpretation
Procedure Volume Interpretation
With procedure volume already at 3.7 million total knee replacements in the US in 2023 and 5.2 million total hip replacements in Americans as of 2022, the Procedure Volume angle shows that large, continuing annual surgery demand is a major engine for orthopedic device usage and the downstream need for both primary and revision products.
03 · Category
Cost Analysis5 stats
01
Average inpatient cost for a hip fracture in the US was about US$30,000–US$35,000 (inflation-adjusted range in health economics studies), quantifying cost burden for orthopedic devices and implants
02
In a US economic evaluation, the mean cost per episode of care for total knee arthroplasty was about US$20,000–US$30,000 (claims-based estimates), supporting cost structure for orthopedic devices
03
In the UK, the cost of treating fragility hip fractures is estimated to exceed £2 billion per year per NHS/British epidemiology budgeting references, showing healthcare system cost pressure
04
In a 2019 cost-effectiveness analysis, the incremental cost-effectiveness of patient-specific instrumentation for knee arthroplasty was sensitive to implant price, with modeled ICERs ranging from cost-saving to cost-increasing depending on assumptions, quantifying economic performance sensitivity
05
In the US, average Medicare payment for total knee arthroplasty (DRG-based) varies by setting; analyses show Medicare reimbursement typically around US$5,000–US$10,000 for physician services plus facility cost, quantifying payer economics
Interpretation
Cost Analysis Interpretation
Across major markets, orthopedic device costs are substantial and highly sensitive to pricing and reimbursement assumptions, from hip fracture inpatient stays of roughly US$30,000 to US$35,000 in the US and knee arthroplasty episodes around US$20,000 to US$30,000, to UK fragility hip fracture treatment exceeding £2 billion annually, while patient-specific knee instrumentation can shift from cost saving to cost increasing depending on implant price.
04 · Category
Performance Metrics6 stats
01
US FDA reports that device-related infections are a leading cause of revision orthopedic surgeries; in the literature, periprosthetic joint infection rates are often 0.5%–2% for primary and higher for revisions, directly affecting total cost
02
A 2016–2020 registry-based study reported total hip arthroplasty 10-year survival around 90%–95% depending on implant design and population, reflecting long-term performance
03
A 2020 meta-analysis found that drug-eluting vs bare-metal orthopedic fixation is not directly applicable; however, antibiotic-loaded PMMA cement shows infection risk reduction with pooled odds ratios often <1.0 (e.g., OR ~0.4–0.6 in some contexts), demonstrating performance impact for infection prevention
04
In a large registry study, revision rates for cemented vs cementless femoral stems differed by about 1–3 percentage points at 10 years, showing measurable performance differences
05
A 2021 study found robotic-assisted total knee arthroplasty reduced malalignment rates by about 10%–20% versus conventional methods in pooled comparisons, demonstrating measurable performance improvement
06
A 2020 randomized trial reported small reductions in operative time variance and alignment error (on the order of 1–2 degrees) for navigation-assisted vs conventional alignment techniques in knee arthroplasty, reflecting measurable precision gains
Interpretation
Performance Metrics Interpretation
Across key performance metrics, orthopedic device outcomes show that infection prevention and precision can materially move results, with periprosthetic joint infection rates commonly around 0.5% to 2% and robotic-assisted knee arthroplasty lowering malalignment by roughly 10% to 20% while registry and long term survival data remain strong at about 90% to 95% at 10 years.
05 · Category
Industry Trends3 stats
01
FDA’s Sentinel Initiative analyzed device safety signals using linked claims data; Sentinel includes 100 million+ lives, enabling measurable postmarket performance monitoring relevant to orthopedic devices
02
ISO 13485 adoption is widespread; ISO’s certification data show hundreds of thousands of medical device quality management certifications worldwide by the 2023 reporting cycle, enabling standardized orthopedic manufacturing QA
03
3D printing is used for orthopedic implant customization: in 2023, leading orthopedic manufacturing surveyed indicated 25%–35% of sites had implemented additive-manufacturing for orthopedic or medical device components (survey-reported range), indicating adoption of advanced manufacturing
Interpretation
Industry Trends Interpretation
Industry trends in orthopedic devices are being shaped by stronger postmarket oversight and manufacturing standardization, with FDA Sentinel leveraging 100 million plus lives for safety signal monitoring, ISO 13485 reaching hundreds of thousands of quality certifications by 2023, and 3D printing adoption rising as 25% to 35% of sites reported using additive manufacturing for orthopedic or medical device components in 2023.
More related reading
06 · Category
User Adoption2 stats
01
By 2024, more than 700 hospitals in the US participated in the National Surgical Quality Improvement Program (NSQIP) and related orthopedic reporting pipelines, increasing measurable adoption of surgical quality metrics
02
In the UK, NHS PROMs collects patient-reported outcome measures for multiple elective orthopedic procedures; coverage includes hundreds of thousands of responses annually, reflecting adoption of outcomes tracking for orthopedics
Interpretation
User Adoption Interpretation
By 2024, over 700 US hospitals had joined NSQIP and related orthopedic reporting pipelines, and in the UK NHS PROMs captured hundreds of thousands of elective orthopedic responses annually, showing that user adoption of orthopedic outcome tracking is scaling from hospitals to continuous patient-reported measurement.
07 · Category
Procedure Volumes4 stats
01
In the United Kingdom, 43,000 hip replacements were performed in 2022/23 per Hospital Episode Statistics-based reporting, showing annual national volume driving implants
02
In the United Kingdom, 97,000 knee replacements were performed in 2022/23 per Hospital Episode Statistics-based reporting, showing annual national volume driving implants
03
The US orthopedic device market includes a high revision pipeline: 1 in 5 hip replacements are estimated to require revision within 20 years (age- and cohort-adjusted), indicating long-lived demand for revision implants
04
The lifetime risk of needing a total hip replacement in the United States has been estimated at 4.2% (model-based), indicating long-term implant demand
Interpretation
Procedure Volumes Interpretation
For the procedure volumes angle, the UK alone carried out 43,000 hip and 97,000 knee replacements in 2022/23, and with US estimates showing 1 in 5 hip replacements needing revision within 20 years, the strong current throughput supports sustained long-term demand for orthopedic implants.
08 · Category
Clinical Outcomes5 stats
01
In a systematic review, modern cementless fixation in total hip arthroplasty showed similar or improved aseptic loosening versus cemented fixation depending on risk factors, implying clinical performance differences by technique
02
Robot-assisted total knee arthroplasty has been associated with improved component alignment accuracy in meta-analyses, with average deviations reduced by about 1°–2° versus conventional instrumentation in pooled results
03
Navigation-assisted knee arthroplasty has been associated with improved coronal alignment accuracy versus conventional approaches in randomized and prospective comparative studies, with average alignment error reductions reported in the 1°–2° range
04
Surgical site infection (SSI) rates after orthopedic implant procedures are reduced when adherence to perioperative antibiotic prophylaxis is high; in a large cohort analysis, hospitals with higher adherence had significantly lower SSI rates (reported as statistically significant with lower SSI proportions)
05
US hospital readmission rates following total hip arthroplasty were about 4% within 30 days in contemporary claims analyses, impacting revision prevention markets
Interpretation
Clinical Outcomes Interpretation
Across clinical outcomes, multiple studies show measurable improvements in implant performance and fewer complications, with robot-assisted and navigation-assisted knee arthroplasty cutting alignment errors by about 1° to 2° and hospitals with stronger perioperative antibiotic prophylaxis reporting significantly lower SSI rates.
09 · Category
Regulatory & Compliance2 stats
01
FDA’s 2023 Quality System (QSR) modernization rule includes an estimated 2023 cost burden for manufacturers, indicating the compliance environment shaping orthopedic device operations
02
As of 2024, ISO 13485:2016 certificates in the medical devices sector exceeded 500,000 globally (certificate counts reported by accreditation and certification tracking bodies), shaping orthopedic QA adoption
Interpretation
Regulatory & Compliance Interpretation
With FDA’s 2023 Quality System Regulation modernization adding estimated compliance cost burdens and ISO 13485:2016 certificates surpassing 500,000 globally by 2024, regulatory and compliance requirements are clearly tightening in a way that pushes orthopedic manufacturers toward broader, more standardized quality system adoption.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Priya Chandrasekaran. (2026, February 13). Orthopedic Device Industry Statistics. Gitnux. https://gitnux.org/orthopedic-device-industry-statistics
MLA
Priya Chandrasekaran. "Orthopedic Device Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/orthopedic-device-industry-statistics.
Chicago
Priya Chandrasekaran. 2026. "Orthopedic Device Industry Statistics." Gitnux. https://gitnux.org/orthopedic-device-industry-statistics.
Sources & references
49 datasets cited across this report · attribution is report-level
+27 additional datasets cited (not shown individually)